Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 05, 2020

SELL
$2.94 - $7.7 $47,375 - $124,077
-16,114 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$2.25 - $5.24 $111,118 - $258,782
-49,386 Reduced 75.4%
16,114 $55,000
Q4 2019

Feb 12, 2020

BUY
$3.08 - $5.9 $63,140 - $120,950
20,500 Added 45.56%
65,500 $263,000
Q3 2019

Nov 15, 2019

BUY
$5.25 - $9.26 $236,250 - $416,700
45,000 New
45,000 $255,000

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Chilton Investment CO Inc. Portfolio

Follow Chilton Investment CO Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chilton Investment CO Inc. with notifications on news.